Patient Power®
Get Email Alerts!
Health Topics
Chronic Myelogenous Leukemia (CML) Health Center
Health Center Home About Our CML Education Center About CML Living with CML Patient Stories Support and Resources News and Views Sign up for...
Search by Keyword:
Search by Health Topic:
View all Health Topics >
1/25/12

Understanding Molecular Response with Respect to Cure for CML

Dr. Neil Shah relates the management of CML, for most chronic phase patients, to the management of high blood pressure; while patients should remain diligent and serious about their treatment, they can expect to live long and healthy lives.  Dr. Shah explains that this level of disease management has led researchers to begin looking for answers to more sophisticated questions. One such research question hopes to refine the expectations CML physicians and patients should have regarding complete and major molecular responses, and for whom treatment interruption may be a viable option.

Get Email Updates:

Get updated automatically when new content about Chronic Myelogenous Leukemia has been posted.
Privacy Policy
Chronic Myelogenous Leukemia

Experts & Guests

Neil Shah, M.D., Ph.D. Neil Shah, M.D., Ph.D.
Co-Leader of the Hematologic Malignancies Program, UCSF Helen Diller Family Comprehensive Cancer Center
Dr. Neil Shah is Co-Leader of the Hematologic Malignancies Program at UCSF Helen Diller Family Comprehensive Cancer Center and Assistant Professor in Division of Hematology/Oncology at the UCSF School of Medicine.  Dr. Shah completed his medical degree and PhD in Microbiology and Molecular Genetics at the University of California, Los Angeles.  more >

Transcript

  1. Understanding Molecular Response with Respect to Cure for CML

Related Videos

with Greg Stephens, Executive Director of the National CML Society (NCMLS)

Watch Now
Dr. Jorge Cortes covers the latest thinking on CML from ASH 2011.

Watch Now
Dr. Druker shares his passion and optimism for the continued advancement of CML research and treatment.

Watch Now